Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

(2010) Eric J. Gowans et al.   JOURNAL OF HEPATOLOGY

CD40 signalling induces IL-10-producing, tolerogenic dendritic cells

(2009) Andrea Tuettenberg et al.   EXPERIMENTAL DERMATOLOGY

Development of hepatitis C virus vaccines: challenges and progress

(2009) Françoise Stoll-Keller et al.   Expert Review of Vaccines

Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy

(2009) Diana Llopiz et al.   INTERNATIONAL JOURNAL OF CANCER

43 A FIRST CLINICAL TRIAL OF THERAPEUTIC VACCINATION USING NAKED DNA DELIVERED BY IN VIVO ELECTROPORATION SHOWS ANTIVIRAL EFFECTS IN PATIENTS WITH CHRONIC HEPATITIS C

(2009) M. Matti Sallberg et al.   JOURNAL OF HEPATOLOGY

42 A NOVEL VECTORIZED HCV THERAPEUTIC VACCINE (TG4040): RESULTS OF A PHASE I STUDY IN NAIVE PATIENTS CHRONICALLY INFECTED BY HCV

(2009) F. Habersetzer et al.   JOURNAL OF HEPATOLOGY

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

(2008) Christoph S. Klade et al.   GASTROENTEROLOGY

Vaccination Against Hepatitis C Virus With Dendritic Cells Transduced With an Adenovirus Encoding NS3 Protein

(2007) Aintzane Zabaleta et al.   MOLECULAR THERAPY